+ Follow us On Google

India’s pharma and healthcare sector witnessed robust deal momentum in Q3 2025, recording a total of 72 transactions valued at USD 3.5 billion, up 28% in volumes and 166% in value quarter on quarter, according to the Grant Thornton report.

Excluding public market activity, private deals accounted for USD 3 billion across 68 transactions, marking a sharp rebound in investor appetite. The surge was driven by seven high value deals worth USD 2.6 billion, the report added.

The surge reflects the sector’s strong fundamentals spanning pharma, biotech and hospital segments.

Mergers and Acquisitions (M&A) landscape

The Grant Thornton report reported M&A activity surged in Q3, recording 36 deals worth USD 2.5 billion, a 57% rise in volumes and a remarkable 12.2x jump in

See Full Page